HVSEN Biotechnology Co., Ltd. (300871) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

HVSEN Biotechnology Co., Ltd.

Why is HVSEN Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 12.73% and Operating profit at 9.34% over the last 5 years

The company has declared Positive results for the last 6 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 240.93 MM
ROCE(HY) Highest at 14.94%
RAW MATERIAL COST(Y) Fallen by -62.25% (YoY)

With ROE of 13.37%, it has a attractive valuation with a 1.54 Price to Book Value

Over the past year, while the stock has generated a return of 15.10%, its profits have risen by 632.6% ; the PEG ratio of the company is 0
At the current price, the company has a high dividend yield of 0.5

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to HVSEN Biotechnology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is HVSEN Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

HVSEN Biotechnology Co., Ltd.

4.16%

2.63

50.40%

China Shanghai Composite

3.0%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.73%

EBIT Growth (5y)

9.34%

EBIT to Interest (avg)

13.19

Debt to EBITDA (avg)

1.93

Net Debt to Equity (avg)

0.32

Sales to Capital Employed (avg)

0.51

Tax Ratio

11.79%

Dividend Payout Ratio

22.47%

Pledged Shares

Institutional Holding

ROCE (avg)

5.06%

ROE (avg)

4.83%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.99

EV to EBIT

14.20

EV to EBITDA

11.03

EV to Capital Employed

1.98

EV to Sales

2.58

PEG Ratio

0.02

Dividend Yield

0.37%

ROCE (Latest)

13.97%

ROE (Latest)

13.37%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 248.36 MM

ROCE(HY)

Highest at 15.63%

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

DIVIDEND PAYOUT RATIO(Y)

Highest at 47.09%

RAW MATERIAL COST(Y)

Fallen by -19.43% (YoY

DIVIDEND PER SHARE(HY)

Highest at CNY 3.03

PRE-TAX PROFIT(Q)

Highest at CNY 133.02 MM

NET PROFIT(Q)

Highest at CNY 116.48 MM

EPS(Q)

Highest at CNY 0.64

-5What is not working for the Company

NET SALES(Q)

Lowest at CNY 406.71 MM

OPERATING PROFIT(Q)

Lowest at CNY 99.16 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 24.38 %

Here's what is working for HVSEN Biotechnology Co., Ltd.

Operating Cash Flow

Highest at CNY 248.36 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

Highest at CNY 133.02 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 133.02 MM has Grown at 55.77%

over average net sales of the previous four periods of CNY 85.39 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 116.48 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.64

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Dividend per share

Highest at CNY 3.03

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio

Highest at 47.09%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -19.43% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for HVSEN Biotechnology Co., Ltd.

Net Sales

Lowest at CNY 406.71 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 99.16 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 24.38 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Non Operating Income

Highest at CNY 0.45 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income

Footer loading